BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 18, 2013
View Archived Issues
Stimulation of developmental pathways to reverse structural and cognitive deficits in trisomy 21
Read More
Update on phase III investigation of a novel radiotracer for the detection of oral carcinoma
Read More
Phase II results presented for blosozumab, a monoclonal antibody targeting sclerostin
Read More
PDI and Transgenomic to commercialize the CardioPredict molecular diagnostic test
Read More
Seragon Pharmaceuticals raises funds to advance pipeline of cancer therapies
Read More
AAA reaches halfway recruitment milestone in phase III Lutathera trial
Read More
Hybrigenics acquires Imaxio's genomics division
Read More
Dance Biopharm forms joint venture with Harmony Asset for inhaled insulin
Read More
Zydus and Pieris enter alliance for novel Anticalin therapeutics
Read More
Phase I trial of KEA-0447/KRP-EPA605 for treatment of overactive bladder begins
Read More
U.S. DoD and MediVector set to advance anti-influenza drug to phase III
Read More
Nosopharm secures funding from French government to support development of new antibiotic class
Read More
Yale researchers begin trial of Halozyme's recombinant hyaluronidase in artificial pancreas
Read More
New drug combination for Parkinson's disease allows lower doses with enhanced clinical effects
Read More
Highly selective DPP IV inhibitor shows outstanding results in vivo
Read More
Merck KGaA patents TANK1/2 inhibitors
Read More
Incozen and Rhizen jointly report HGF receptor inhibitors
Read More
Novel BTK inhibitors described in Takeda patent
Read More
Canadian researchers design SH2 domain variants
Read More
Rebiotix begins phase II trial in recurrent Clostridium difficile-associated diarrhea
Read More
Omeros reports additional data from phase I OMS-824 program
Read More
Relypsa reports topline data from phase IIb trial of patiromer
Read More
Misodel vaginal delivery system approved for labor induction in Europe
Read More
Phase Ia VGX-100 trial completes patient enrollment
Read More
Studies support serum biomarker test to predict optimal treatment, long-term outcome in HF patients
Read More